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Elevations of the levels of N-acetyl-aspartyl-glutamate (NAAG) and N-acetyl-aspartate (NAA) are associated with myelin loss in
the leucodystrophies Canavan’s disease and Pelizaeus-Merzbacher-like disease. NAAG and NAA can activate and antagonize
neuronal N-methyl-D-aspartate (NMDA) receptors, and also act on group II metabotropic glutamate receptors. Oligodendrocytes
and their precursors have recently been shown to express NMDA receptors, and activation of these receptors in ischaemia leads
to the death of oligodendrocyte precursors and the loss of myelin. This raises the possibility that the failure to develop myelin,
or demyelination, occurring in the leucodystrophies could reﬂect an action of NAAG or NAA on oligodendrocyte NMDA
receptors. However, since the putative subunit composition of NMDA receptors on oligodendrocytes differs from that of
neuronal NMDA receptors, the effects of NAAG and NAA on them are unknown. We show that NAAG, but not NAA, evokes
an inward membrane current in cerebellar white matter oligodendrocytes, which is reduced by NMDA receptor block (but not by
block of metabotropic glutamate receptors). The size of the current evoked by NAAG, relative to that evoked by NMDA, was
much smaller in oligodendrocytes than in neurons, and NAAG induced a rise in [Ca
2+]i in neurons but not in oligodendrocytes.
These differences in the effect of NAAG on oligodendrocytes and neurons may reﬂect the aforementioned difference in
receptor subunit composition. In addition, as a major part of the response in oligodendrocytes was blocked by tetrodotoxin
(TTX), much of the NAAG-evoked current in oligodendrocytes is a secondary consequence of activating neuronal NMDA
receptors. Six hours exposure to 1mM NAAG did not lead to the death of cells in the white matter. We conclude that
an action of NAAG on oligodendrocyte NMDA receptors is unlikely to be a major contributor to white matter damage in the
leucodystrophies.
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The speeding of axon potential propagation which is produced by
myelination of axons by oligodendrocytes is essential for normal
brain function (Fields, 2008). Failure of the development of
myelination, as occurs in genetic leucodystrophies and cerebral
palsy, or destruction of myelin, as occurs in multiple sclerosis,
produces mental and physical disability. It has become increasingly
clear that activation of glutamate receptors on oligodendrocytes,
or their precursor cells, can lead to loss of myelin. Periventricular
leucomalacia, leading to cerebral palsy, can be caused by a
deﬁcient blood ﬂow to the periventricular white matter and/or
infection, leading to glutamate release that kills precursor and
immature oligodendrocytes (Follett et al., 2000; Ka ´rado ´ttir et al.,
2008; Khwaja and Volpe, 2008). In spinal cord injury, secondary
ischaemia leads to a release of glutamate by reversed uptake from
axons and from oligodendrocytes themselves, which damages
oligodendrocytes by activating AMPA/kainate receptors (Li et al.,
1999). Oligodendrocytes also express N-methyl-D-aspartate
(NMDA) receptors, however, and activation of these receptors by
glutamate released in ischaemia causes demyelination and loss
of axonal action potential propagation (Ka ´rado ´ttir et al., 2005;
Salter and Fern, 2005; Micu et al., 2006; Bakiri et al., 2008).
Other endogenous molecules may also act on oligodendrocyte
NMDA receptors. In particular, N-acetyl-aspartate (NAA) and
N-acetyl-aspartyl-glutamate (NAAG) have been shown to act as
both agonists and antagonists at neuronal NMDA receptors
(Westbrook et al., 1986; Sekiguchi et al., 1992; Burlina et al.,
1994; Koenig et al., 1994; Valivullah et al., 1994; Rubin et al.,
1995; Pliss et al., 2000; Bergeron et al., 2005). NAA and NAAG
are synthesized in neurons (Baslow, 2007), as shown in Fig. 1.
NAA can be exported to oligodendrocytes, where it is metabolized
by the enzyme aspartoacylase, to form acetyl-CoA, which has
been suggested to be used for myelination (Chakraborty et al.,
2001), although this idea has been criticized (Baslow, 2007) on
the grounds that NAA turns over much faster than myelin,
and that myelin is still formed in a disorder in which NAA is no
longer made. NAAG is broken down to NAA and glutamate by
glutamatecarboxypeptidases (Berger et al., 1999) located on the
surface of astrocytes (Fig. 1).
In two leucodystrophies there is a defect in the metabolism of
NAAG and NAA, associated with a lack of formation of myelin.
Canavan’s disease is caused by a lack of aspartoacylase activity
(Fig. 1) in oligodendrocytes (Kumar et al., 2006), which reduces
NAA breakdown and thus causes a large rise in NAA and NAAG
levels. Patients have also been reported with a Pelizaeus-
Merzbacher-like syndrome, in which there is an absence of
myelin similar to that seen when the myelin proteolipid protein
is mutated in Pelizaeus-Merzbacher disease (although no mutation
was found in these patients), and this is associated with a large
rise of NAAG concentration (Wolf et al., 2008). Because NAA and
NAAG levels rise in these disorders, and because these agents
affect neuronal NMDA receptors, we hypothesized that
the demyelination occurring in these disorders might reﬂect NAA
or NAAG acting on oligodendrocyte NMDA receptors. However,
the subunit composition of oligodendrocyte NMDA receptors most
probably differs from that of neuronal ones (Ka ´rado ´ttir et al.,
2005; Salter and Fern, 2005; Micu et al., 2006), and so may
show a different pharmacological proﬁle. We therefore tested
whether NAAG or NAA can act on oligodendrocyte NMDA
receptors.
Methods
Preparation
Rats (post-natal day 12) were killed by cervical dislocation
in accordance with UK government regulations. Cerebellar slices
(225mm thick) were made in solution containing 124mM NaCl,
26mM NaHCO3, 1mM NaH2PO4, 2.5mM KCl, 2mM MgCl2,
2.5mM CaCl2, 10mM glucose, bubbled with 95% O2/5% CO2,p H
7.4, as well as 1mM Na-kynurenate to block glutamate receptors. For
experiments, slices were superfused at 241C with HEPES-buffered
solution containing 144mM NaCl, 2.5mM KCl, 10mM HEPES, 1mM
NaH2PO4, 2.5mM CaCl2, 10mM glucose, pH set to 7.4 with NaOH,
bubbled with 100% O2. Usually MgCl2 was omitted from the solution,
and glycine (100mM, to ensure activation of the glycine site of NMDA
receptors) and strychnine (5mM, to block glycine-gated chloride
channels) were added. Some experiments, shown in Figs 9 and 10,
were performed in physiological (1mM) Mg
2+ and with no
added glycine. NAA and NAAG were from Tocris, UK. HPLC data
supplied by Tocris showed that 1mM NAAG contained 50.2mM
glutamate.
Electrophysiology
White matter cells (avoiding cerebellar nuclei) were whole-cell
clamped with pipettes containing a Cs
+-based solution comprising
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Figure 1 Metabolic pathways of NAA and NAAG. NAA is
synthesized in neurons from aspartate and acetyl-CoA. It can
then be exported to oligodendrocytes, where it is converted
back to acetyl-CoA by aspartoacylase (an enzyme lost in
Canavan’s disease) and may thus be converted into lipids that
form part of the myelin. Alternatively, it can be converted to
NAAG in neurons and released to the extracellular space,
where it is converted back to NAA by carboxypeptidases
expressed on the extracellular surface of astrocytes.
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10mM BAPTA, 4mM MgATP, 0.5mM Na2GTP, K-Lucifer yellow 2,
pH set to 7.3 with CsOH. Membrane potentials were compensated
for the –14mV junction potential measured with the electrode in
the extracellular solution (Fenwick et al., 1982). Series resistance
was 10–30MV. Mature oligodendrocytes were identiﬁed from their
morphology after Lucifer ﬁlling, with a small number of cells also
being labelled after recording for myelin basic protein (as in
Ka ´rado ´ttir et al., 2005; Ka ´rado ´ttir and Attwell, 2006). Granule cells
were identiﬁed from their position in the granule cell layer, their small
soma attached to approximately four dendrites and their high input
resistance (43GV).
[Ca
2+]i imaging with Fluo-4-AM
Slices were loaded with the acetoxymethyl ester of Fluo-4 by
incubating slices for 2h in a 10mM solution of Fluo-4-AM (a 2mM
Fluo-4-AM stock was made by dissolving 50mg of the ester in 11.5ml
of 20% pluronic acid in DMSO, and adding 11.5ml of DMSO;
then 10ml of this stock was added to 2ml of slicing medium).
95% O2/5% CO2 was blown gently over the solution while loading.
Fluorescence was excited at 48810nm and emitted light was
collected at 53522nm. Regions of interest in the white and
grey matter were identiﬁed from the morphology and anatomy of
the slice. If the slices were not loaded with dye the baseline ﬂuores-
cence was 2.99-fold lower for white matter and 3.37-fold lower
for grey matter (comparing 12 loaded and three unloaded slices)
and there was a negligible ﬂuorescence (F) change in response
to 1mM NAAG (F/F=–0.001460.00146 in three unloaded
slices, compared with 0.036110.0095 in the white matter of
12 loaded slices).
Single cell [Ca
2+]i imaging
White matter oligodendrocytes and grey matter granule cells were
patch-clamped with pipettes containing a Cs
+-based solution compris-
ing 130mM Cs-gluconate, 4mM NaCl, 10mM HEPES, 0.01mM
BAPTA, 10mM phosphocreatine, 4mM MgATP, 0.5mM Na2GTP,
1mM Fura-2, pH set to 7.3 with CsOH. Fluorescence was excited
sequentially at 34010 and 38010nm, and emitted light
was collected at 51020nm. The ratio of the emission intensities
(340/380nm) was used as a measure of increased [Ca
2+]i, and
only ratios that reﬂected both a decrease of ﬂuorescence excited
at 380nm and an increase in ﬂuorescence excited at 340nm
were used.
Cell death assay
Slices were bathed in a HEPES-buffered solution (containing 144mM
NaCl, 2.5mM KCl, 10mM HEPES, 1mM NaH2PO4, 2.5mM CaCl2,
1mM MgCl2, 10mM glucose, pH set to 7.4 with NaOH, bubbled with
100% O2) containing 1mM NAAG, or 1mM NAAG and 100mM AP5,
or 100mM NMDA, or control solution, at 36C for 6h. Propidium
iodide (PI, Sigma, 37mM) was added to reveal a loss of membrane
permeability associated with cell death. Slices were then ﬁxed in 4%
paraformaldehyde overnight, washed twice for 15min in phosphate
buffered saline (PBS) and preincubated for 4h in 0.05% Triton
and 10% normal goat serum in PBS. To identify the white matter,
antibody to myelin basic protein (MBP, mouse, Chemicon, 1:150)
was applied overnight, followed by 330min PBS washes and
8h incubation with secondary antibody (goat anti-mouse IgG,
AlexaFluor 488, Invitrogen, 1:200). Slices were washed 330min
with PBS and mounted on coverslips using a mounting solution
containing DAPI to label nuclei.
Confocal microscopy
Confocal images of slices were taken for the cell death assay using
excitation and emission wavelengths as follows: DAPI (excitation
364nm, emission4385nm), AlexaFluor 488 (excitation 488nm, emis-
sion 505–530nm) and PI (excitation 543nm, emission 570–600nm).
A4 0 objective was used to take pictures of the white matter
(MBP-positive) and grey matter (MBP-negative) in each slice.
The percentage of dead cells was calculated as the number of
PI-positive cells divided by the total number of cells with DAPI-labelled
nuclei.
Statistics
Data are presented as meanSEM. P-values are from Student’s
two-tailed t-tests.
Results
The effect of NAA and NAAG on
oligodendrocyte and granule cell
currents
We compared the effect of 1mM NAAG, 1mM NAA and 60mM
NMDA on mature oligodendrocytes and granule cells in cerebellar
slices, both of which have previously been reported to show
NMDA-evoked currents (D’Angelo et al., 1993; Ka ´rado ´ttir et al.,
2005). High concentrations of NAA and NAAG were used to
determine whether there was any possibility of these agonists
activating the cells’ NMDA receptors, because earlier work
(Westbrook et al., 1986; Rubin et al., 1995) demonstrated a
low potency for these compounds’ action on neuronal NMDA
receptors. NAA, NAAG and NMDA were usually applied in
Mg
2+-free solution containing glycine (100mM) to ensure
adequate activation of the receptors’ glycine/D-serine site
(although, at least in the grey matter of the cerebellum, this
site is saturated by endogenously released glycine or D-serine:
Billups and Attwell, 2003), but we show below (Fig. 9)
that NAAG also evokes a current in oligodendrocytes in solution
lacking added glycine and containing a physiological level of Mg
2+
(1mM).
NAAG evoked a signiﬁcant inward current in oligodendrocytes
(Fig. 2A), which was 7% of the current evoked by NMDA in the
same cells (Fig. 2B, which also includes data for NMDA in a small
number of cells to which NAA but not NAAG was applied), while
NAA evoked no detectable current. In contrast, in granule cells
the NAAG-evoked current was 77% of the current evoked by
NMDA in the same cells, and NAA also evoked a small but
signiﬁcant current (Fig. 2C and D).
1498 | Brain 2009: 132; 1496–1508 K. Kolodziejczyk et al.Pharmacology of the NAAG-evoked
current
The NMDA receptor blocker D-AP5 (100mM) reversibly blocked
the NAAG-evoked current both in oligodendrocytes (Fig. 3A and
B) and in granule cells (Fig. 3C and D). The incomplete block of
the NAAG-evoked current in oligodendrocytes in Fig. 3B probably
reﬂects the inaccuracies of measuring the very small current
evoked by NAAG in the presence of small baseline current
variations. Since NAAG has also been reported to act on metabo-
tropic glutamate (mGluR3) receptors (Wroblewska et al., 1997,
1998), we tested the effect on the NAAG-evoked current of the
group II mGluR antagonist EGLU [(2S)-a-ethylglutamic acid]. At a
concentration of 200mM, i.e. three times the Ki value for mGluR3
inhibition (Jane et al., 1996), EGLU had no effect on the NAAG-
evoked current in oligodendrocytes (Fig. 3E and F), leading to the
conclusion that all of this current is the result of NAAG activating
NMDA receptors—however, this does not rule out the possibility
that NAAG evokes mGluR3 mediated effects which are not
detected as a current.
NAAG and NAA are not strong blockers
of NMDA receptors
Since the role of NMDA receptors in controlling and maintaining
myelination is not yet known, it seemed possible that a demyelin-
ating action of NAAG or NAA might occur if these agents blocked
NMDA receptors and thus inhibited normal signalling from axons
to oligodendrocytes or their precursors. Block of neuronal NMDA
receptors by NAAG has been reported previously (Burlina et al.,
1994; Bergeron et al., 2005).
However, when 1mM NAA or NAAG were applied during
the response to NMDA in white matter oligodendrocytes, any
reduction in the NMDA-evoked current they produced was small
compared with the reduction occurring anyway as a result of
receptor desensitization (Fig. 4A–C; reduction of the response by
NAAG/NAA was estimated by ﬁtting a straight line to the
desensitization, and measuring the actual current at the end of
the NAAG/NAA application relative to the interpolated value
that would occur without NAAG/NAA). In some granule cells
both NAA and NAAG produced a small reduction of the
NMDA-evoked current (Fig. 4D and E), but in others the reduction
was minimal (the mean reduction is shown in Fig. 4F). Thus, even
using 1mM NAA or NAAG produced much less inhibition of the
oligodendocyte or granule cell NMDA response than the 80%
block reported to be produced by NAAG concentrations above
20mM in hippocampal pyramidal neurons (Bergeron et al., 2005).
Part of the oligodendrocyte NAAG
response is produced by hydrolysis
to glutamate
Extracellular NAAG, whether generated endogenously or applied
exogenously, can be converted to glutamate by carboxypeptidases
II and III on the extracellular surface of astrocytes (Fig. 1; Berger
et al., 1999; Bzdega et al., 2004). To test whether the response of
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Figure 2 NAAG, NAA and NMDA-evoked whole cell currents at –74mV in white matter oligodendrocytes and cerebellar granule
cells. (A) Representative trace shows current response to 1mM NAAG, 1mM NAA and 60mM NMDA in a single oligodendrocyte.
(B) Average responses to 1mM NAAG (n=20 cells), 1mM NAA (n=5) and 60mM NMDA (n=12) in oligodendrocytes. (C)
Representative trace shows response to 1mM NAAG, 1mM NAA and 60mM NMDA in a single granule cell. (D) Average responses to
1mM NAAG (n=14), 1mM NAA (n=14) and 60mM NMDA (n=13) in granule cells.
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derived glutamate, we blocked these enzymes with 10mM
2-PMPA [2-(phosphonomethyl)pentanedioic acid], (Jackson
et al., 1996): the IC50 values for inhibition of GCP II and III
are 6.7 and 0.9 nM, respectively (Bzdega et al., 2004).
This concentration of 2-PMPA does not signiﬁcantly block
NMDA receptors (Tortella et al., 2000).
We found an interesting variability in the effect of 2-PMPA.
In some oligodendrocytes (Fig. 5A) the NAAG response was
unaffected by blocking this enzyme, suggesting that the NAAG-
evoked current was produced by NAAG itself (HPLC data provided
by Tocris showed that 1mM NAAG solution contained 50.2mM
contaminating glutamate), while in other cells the enzyme blocker
signiﬁcantly reduced the response (Fig. 5B) implying that part of
the response was produced by conversion of NAAG to glutamate
by endogenous carboxypeptidases. On average, about 60% of
the response was blocked by 2-PMPA (Fig. 5C).
The NAAG response in
oligodendrocytes is partly produced
by neuronal action potentials
Superfusion of NAAG (or NMDA) could, in principle, evoke a
current in oligodendrocytes by acting directly on oligodendrocyte
NMDA receptors, or by acting on neuronal NMDA receptors to
increase neuronal ﬁring and hence increase the release of factors
like K
+ from axons, which may generate a current in oligodendro-
cytes. The large NMDA-evoked current is not signiﬁcantly affected
by tetrodotoxin (TTX) (Ka ´rado ´ttir et al., 2005), suggesting that
essentially all of the NMDA-evoked current is generated by a
direct action on oligodendrocytes. However, 1mM TTX reduced
the NAAG-evoked current by 77% (Fig. 5D and E), suggesting
that much of the NAAG response is generated indirectly by NAAG
activating neuronal NMDA receptors and increasing action poten-
tial ﬁring (see Discussion section). In contrast, TTX did not affect
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Figure 3 Pharmacology of the NAAG-evoked current at –74mV in white matter oligodendrocytes and cerebellar granule cells.
(A) Representative trace shows response to 1mM NAAG and block of the response by 100mM AP5 in a white matter oligodendrocyte.
(B) Mean effect on the response to 1mM NAAG of 100mM AP5 in 10 white matter oligodendrocytes. The second and third bars are
normalized to the initial NAAG response (as 100%), and show the response to NAAG in the presence of AP5 and the response to
a subsequent application of NAAG alone. P-value compares the response in NAAG to the average of the preceding and subsequent
responses without AP5. (C) Representative trace shows response to 1mM NAAG alone and block of the response by 100mM AP5 in
a granule cell. (D) Mean effect on the response to 1mM NAAG of 100mM AP5 in four granule cells. (E) Representative trace shows
effect on 1mM NAAG-evoked response of 200mM EGLU in white matter oligodendrocyte. (F) Mean effect of 200mM EGLU on the
response to 1mM NAAG in three white matter oligodendrocytes. Response in EGLU was measured at the end of EGLU application,
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2.48.2%, not signiﬁcant, P=0.79).
Effects of NAAG and NAA on [Ca
2+]i
in the white matter and grey matter
The death of oligodendrocyte lineage cells and lack of myelin that
occur in Canavan’s disease and in Pelizaeus-Merzbacher-like
disease may be generated by a rise of [Ca
2+]i in oligodendrocytes.
To determine whether NAAG or NAA raise [Ca
2+]i in cells of
the white matter, we initially employed the Ca
2+-sensitive dye
Fluo-4, which was loaded into the cells of cerebellar slices as
its acetoxymethyl ester. Regions of interest were imaged that
included, separately, the white matter and the grey matter
(Fig. 6A).
In both the grey and the white matter, NAAG and NMDA evoked
an increase in Fluo-4 ﬂuorescence, while NAA did not (Fig. 6B–D).
As for the membrane currents shown for grey matter granule cells
and white matter oligodendrocytes in Fig. 2, the response to NAAG,
relative to that for NMDA, was larger in the grey matter than in the
white matter. In addition, in both areas the ratio of the NAAG
response to that for NMDA (measured in the same slice or cell)
tended to be larger for the calcium response than for the current
response (NAAG/NMDA=0.370.14, n=9, for white matter
[Ca
2+]i and 0.0660.014, n=10, for oligodendrocyte current,
signiﬁcantly different: P=0.03; NAAG/NMDA=1.740.57,
n=9, for grey matter [Ca
2+]i and 0.770.24, n=7, for granule
cell current, not signiﬁcantly different: P=0.18). D-AP5
(100mM) decreased the ﬂuorescence change evoked by NMDA
(data not shown) and by NAAG, both in white and grey matter
(Fig. 7).
The effect of NAAG on [Ca
2+]i in
oligodendrocytes and granule cells
Although AM-loading of the calcium dye Fluo-4 led to granule
cells generating sufﬁcient ﬂuorescence for their calcium responses
to be reliably distinguished from those generated in surrounding
cells, this was not the case for the very ﬁne processes of oligo-
dendrocytes in the white matter. To determine whether the cells in
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2+]i rise are
oligodendrocytes, we patch-clamped cells whose morphology
(assessed after Lucifer yellow ﬁlling from the patch pipette)
corresponded to mature oligodendrocytes, using pipettes contain-
ing the ratiometric Ca
2+-sensitive dye Fura-2. As a control, we also
patch-clamped granule cells in grey matter.
In oligodendrocytes, 1mM NAAG did not evoke a signiﬁcant
[Ca
2+]i rise in either the cell body or the processes, despite NAAG
evoking an inward current (Fig. 8A, C and E), and despite
spontaneous [Ca
2+]i elevations being observed, so we knew that
the dye was working. Granule cells, however, responded to 1mM
NAAG with a statistically signiﬁcant [Ca
2+]i rise (both in their
processes and cell body) that was blocked by D-AP5 (Fig. 8B,
D–F). The implications of these results are considered in the
Discussion section.
The effect of pathologically relevant
levels of NAAG
In Canavan’s disease the extracellular NAA concentration
(assessed in the CSF) rises from its baseline value of 1.5mM
(Jakobs et al., 1991) to 0.4–0.9mM (Wevers et al., 1995;
Burlina et al., 1999) i.e. less than the 1mM concentration we
have applied which produces no effect on oligodendrocytes, and
the NAAG level rises from its normal value of 1–10 to 20mM
(Burlina et al., 1999). In Pelizaeus-Merzbacher-like disease, the
NAAG concentration has been reported to rise to 50mM
(Sartori et al., 2008) or 200mM (Wolf et al., 2004). We there-
fore, tested the effect of 50 and 200mM NAAG on the membrane
current and [Ca
2+]i change of oligodendrocytes and granule cells.
In both oligodendrocytes (Fig. 9A and B) and granule cells (Fig. 9E
and G) 50mM NAAG produced a barely detectable current, while
200mM NAAG evoked a signiﬁcant current in 0mM Mg
2+. NAAG
(200mM and 1mM) also evoked a current in oligodendrocytes in
the presence of a physiological Mg
2+ concentration (1mM:
Fig. 9C and D). As in Fig. 8, a [Ca
2+]i rise was seen in granule
cells but not in oligodendrocytes, which increased with increasing
NAAG concentration (Fig. 9E and F).
The effect of NAAG on cell death in
white matter and grey matter
As NAAG evokes an inward current in oligodendrocytes of the
cerebellar white matter, and an inward current and [Ca
2+]i rise
in granule neurons of grey matter, we hypothesized that a
direct or indirect effect of this molecule on oligodendrocytes
may lead to their death and hence to the myelin loss observed
in Canavan’s and Pelizaeus-Merzbacher-like diseases. We checked
this theory by bathing cerebellar slices in extracellular solution
containing a physiological level of Mg
2+ (1mM, with no added
glycine) and 1mM NAAG, 1mM NAAG with 100mM AP5,
100mM NMDA or no NMDA agonists, at 36C for 6h.
Afterwards, we labelled the slices with antibody to myelin basic
protein to deﬁne the white matter and with DAPI to deﬁne cell
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(i.e. took up propidium iodide into their soma) in the white
matter and the grey matter.
Although NMDA evoked signiﬁcant death of granule cells in
the grey matter (P=0.004), NAAG did not, and neither NAAG
nor NMDA evoked signiﬁcant cell death in the white matter
(Fig. 10). The relevance of these data to the loss of myelin
occurring in the leukodystrophies is discussed below.
Discussion
The levels of NAA and NAAG rise in several leucodystrophies, and
these agents have previously been shown to activate neuronal
NMDA receptors. Our data show, for the ﬁrst time, that the rise
of NAAG concentration occurring in the leucodystrophies also
evokes a membrane current in oligodendrocytes.
The NAAG evoked current, in both cerebellar granule cells and
oligodendrocytes, was blocked by D-AP5 but not by a blocker of
mGluR3 receptors (which NAAG can also activate), showing that
the current is produced by the activation of NMDA receptors.
However, our data show that NAAG and NAA have much
less effect on the type of NMDA receptor that is expressed in
oligodendrocytes than on those in granule cells, presumably
because the oligodendrocyte receptors have a different subunit
composition (Ka ´rado ´ttir et al., 2005; Salter and Fern, 2005;
Micu et al., 2006). Thus, in granule cells 1mM NAAG evokes a
current which is about 3/4 the size of that evoked by 60mM
NMDA, and 1mM NAA evokes a detectable current, while in
oligodendrocytes the NAAG-evoked current is only about 7% of
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current (Fig. 2).
The potency of NAAG at oligodendrocyte NMDA receptors is
even less than is suggested by inspection of Fig. 2, because a
signiﬁcant fraction of the NAAG response in oligodendrocytes
is generated indirectly. A major part of the response is blocked
by TTX (Fig. 5E), and so presumably reﬂects NAAG acting on
neuronal NMDA receptors to increase neuronal ﬁring, which
then releases a substance, perhaps K
+, which generates an
inward current in the oligodendrocytes. Blocking carboxypepti-
dases also reduced the response to NAAG (Fig. 5C), implying
that part of the NAAG-evoked current is generated by NAAG
being converted to glutamate (Fig. 1), and this will presumably
also be the case for endogenously generated NAAG.
NAAG evoked a rise of calcium concentration which was easily
detectable in the grey matter but small in the white matter, as
assessed with AM-loading of a Ca
2+-sensing dye (Figs 6 and 7),
and when individual cells were studied by loading Ca
2+ dye from
the patch pipette, although granule cells in the grey matter
showed a robust [Ca
2+]i rise mediated by NMDA receptors, oligo-
dendrocytes did not (Fig. 8). These data suggest that the small
[Ca
2+]i rise detected with AM dye loading in the white matter
does not originate from oligodendrocytes. Oligodendrocytes may
not generate a [Ca
2+]i rise because the presence of NR3 subunits
in their NMDA receptors reduces their Ca
2+ permeability
(Chatterton et al., 2002). In addition, as described above, NAAG
does not activate oligodendrocyte NMDA receptors well, and the
current it generates in these cells partly reﬂects an indirect effect
(mediated by NAAG activating NMDA receptors on neurons),
which may not generate a Ca
2+ inﬂux.
Exposure for 6h to even 1mM NAAG (in a physiological Mg
2+
concentration) did not produce signiﬁcant cell death in either the
grey or the white matter (Fig. 10). We note, however, that 6h
exposure to NAAG may not reﬂect the effect of the more
prolonged pathological exposure occurring in the leucodystrophies
and, in addition, NMDA receptor activating agonists can
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killing the soma (Salter and Fern, 2005; Micu et al., 2006),
which might make propidium iodide labelling an unreliable
indicator of myelin loss.
In summary, we have tested the hypothesis that the
elevation of NAAG and NAA concentrations that occurs in the
leucodystrophies might damage oligodendrocytes by acting on
oligodendrocyte NMDA receptors. Our data show that NAAG
evokes an inward current both in oligodendrocytes and granule
cells, along with a calcium concentration change in the latter.
NAAG is a low afﬁnity agonist at NMDA receptors, but does
produce a signiﬁcant current in both cell types at a pathologically
relevant concentration of 200mM (Fig. 9). However, NAAG is a
much less effective agonist at oligodendrocyte NMDA receptors
than at neuronal NMDA receptors, and the small current gener-
ated in oligodendrocytes by NAAG largely reﬂects a secondary
consequence of its activation of neuronal NMDA receptors.
Thus, if the elevation of NAAG concentration in the leucodystro-
phies causes white matter damage, this will most likely be
initiated by it activating neuronal NMDA receptors and changing
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